Sotabase

Career

· Chief Science Officer, Style3D2022–
· Associate Professor, The Ohio State University2018–2022
· Assistant Professor, The Ohio State University2011–2018
· Postdoctoral Researcher, UC Berkeley2009–2011
· Doctor of Philosophy (PhD), Computer Science, Georgia Institute of Technology2004–2009

Publications (353)

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Nature · 2014
1,118
cited
Recent Advances in Radical C-H Activation/Radical Cross-Coupling.
Chemical Reviews · 2017
914
cited
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.
Cancer Research · 2009
853
cited
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
Annals of Surgical Oncology · 2006
846
cited
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.
Journal of Clinical Oncology · 2008
718
cited
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Cell · 2014
651
cited
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
Journal of Clinical Oncology · 2008
593
cited
Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
Annals of Surgery · 2007
574
cited
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Nature Communications · 2017
522
cited
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
Cancer · 2012
501
cited
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Annals of Surgical Oncology · 2009
481
cited
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.
Journal of Clinical Oncology · 2008
457
cited
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
Cancer Cell · 2012
445
cited
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases
Cancer · 2007
401
cited
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Nature Protocols · 2009
377
cited
Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer
Journal of Experimental Medicine · 2020
346
cited
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin‐associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis
Histopathology · 2010
314
cited
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
Molecular Carcinogenesis · 2008
298
cited
Data-driven elastic models for cloth: modeling and measurement
ACM Transactions on Graphics · 2011
290
cited
ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma
PLoS ONE · 2011
275
cited
Sotabase